| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/18/2004 | CN1138785C Application of growth factor neuregulin and its analogs |
| 02/18/2004 | CN1138771C 6-hydroxy-3-(4-[2-piperidine-1-group) oxyethyl group] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride salt |
| 02/18/2004 | CN1138770C 6-carbonyl-3-(4-[2-pierid-1-yl)elhoyl]phenoxy)-2-(4-methoxylphenyl) benzo[b] thiophene salt crystal |
| 02/18/2004 | CN1138591C Coated particles, method of making and using |
| 02/18/2004 | CN1138579C Diffusional implantable delivery system |
| 02/18/2004 | CN1138562C Use of muteins of wild-type cytokines as immunogens |
| 02/18/2004 | CN1138561C Chewing gum for preventing decayed tooth and its preparing process |
| 02/18/2004 | CN1138560C Method for control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 02/18/2004 | CN1138550C Process of producing extracts of shark |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |
| 02/18/2004 | CN1138536C Oil/water fat emulsion or its application of freeze dry composition |
| 02/18/2004 | CN1138531C Dispersible macromolecule compositions and method for their preparation and use |
| 02/18/2004 | CN1138528C Peptide/protein suspension temper |
| 02/18/2004 | CN1138527C Osmotic device with delayed activation of drug delivery and complete drug release |
| 02/18/2004 | CN1138505C Anti-angiogenic compositions and method of use |
| 02/18/2004 | CN1138472C Dipeptide apoptosis inhibitors and use thereof |
| 02/17/2004 | WO2004006898A3 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 02/17/2004 | USRE38431 Stable liquid formulations of factor viii and factor ix to provide a constant level of the coagulation factor in the blood |
| 02/17/2004 | US6693186 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 02/17/2004 | US6693183 MURINE α (1,3) FUCOSYLTRANSFERASE FUC-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 02/17/2004 | US6693182 Mammalian galanin receptors |
| 02/17/2004 | US6693174 Nucleotide sequences coding fungicide for use in the prevention of fungal infections |
| 02/17/2004 | US6693173 Removing multivalent ions from protein; obtain solution containing protein, adjust hydrogen ion concentration, diafilter solution, recover retentate |
| 02/17/2004 | US6693171 ACPL polypeptides |
| 02/17/2004 | US6693170 ARIP4 gene and protein |
| 02/17/2004 | US6693168 Chiral cyanoamines and methods of preparation |
| 02/17/2004 | US6693166 Cdk5—specific inhibitory peptides |
| 02/17/2004 | US6693165 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/17/2004 | US6693120 Spray drying of thrombin inhibitors |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693096 Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
| 02/17/2004 | US6693086 Eliciting nonantigen and strong antigen specific immune response; cancer, allergic inflammation and/or infectious disease prevention |
| 02/17/2004 | US6693083 Intracellular drug delivery into an interleukin-2 receptor-bearing cell includes a chemical agent and a copy of an interleukin-2-receptor binding and endocytosis-inducing ligand bound to a water soluble polymer |
| 02/17/2004 | US6693082 Method of inhibiting metastatic dissemination using desmopressin |
| 02/17/2004 | US6693081 Bone stimulating factor |
| 02/17/2004 | US6693079 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693078 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693077 Keratinocyte growth factor-2 |
| 02/17/2004 | US6693076 Treating disorders by application of insulin-like growth factors and analogs |
| 02/17/2004 | US6693075 Factor viia polypeptide comprising modified carboxyglutamic acid domain; enhancing membrane binding affinity and activity |
| 02/17/2004 | US6693074 Cystine depleted glycoprotein hormones |
| 02/17/2004 | US6693073 Pulmonary delivery of active agents |
| 02/17/2004 | US6693072 Short, synthetic peptides; antiinflammatories for neutrophil associated diseases |
| 02/17/2004 | US6692960 Gene expression inhibition; treating developmental disorders or aberrant apoptosis |
| 02/17/2004 | US6692959 Hybrid nucleic acids; prevent, controlling gene expression; antiinflammatory agents |
| 02/17/2004 | US6692958 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692948 Isolated human kinase proteins |
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases |
| 02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
| 02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
| 02/17/2004 | US6692935 Fusion of peptide or protein association domains designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides |
| 02/17/2004 | US6692931 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof |
| 02/17/2004 | US6692927 Kit for use in diagnosis and treatment of tumors |
| 02/17/2004 | US6692926 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their use |
| 02/17/2004 | US6692925 Determining if a substance inhibits tgf- beta / alk1 induced smad1 phosphorylation |
| 02/17/2004 | US6692920 Antibody which specifically binds to a polypeptide comprising a naturally occurring ammo acid sequence of a novel expressed chemokine (adec) from inflamed adenoid tissue |
| 02/17/2004 | US6692910 Controlling, reducing gene expression; genetic engineering; viricides; anticancer agents; genetic disorders |
| 02/17/2004 | US6692908 Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor |
| 02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
| 02/17/2004 | US6692770 Suitable for parenteral administration, preferably via injection comprising amylopectin |
| 02/17/2004 | US6692753 Potentiation of the immune response |
| 02/17/2004 | US6692751 Methods and systems for producing recombinant viral antigens |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6692749 Immunogenic composition comprising epstein-barr virus gp350 protein containing deletion of both transmembrane region and c-terminus, substantially free from gp220 protein |
| 02/17/2004 | US6692748 Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 |
| 02/17/2004 | US6692747 Peptide for use in the treatment of infections, viral and cancer diseases |
| 02/17/2004 | US6692746 Tumor killing effects of enterotoxins, superantigens, and related compounds |
| 02/17/2004 | US6692745 Retards binding of glycoprotein to cell surface; viricides |
| 02/17/2004 | US6692743 Apoptosis of naive human NK cells by crosslinking of their FcγRIIIa molecules with a rat IgG2b (LO-CD2a/BTI-322) or its IgG1 humanized monoclonal antibody |
| 02/17/2004 | US6692742 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
| 02/17/2004 | US6692740 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases |
| 02/17/2004 | US6692738 Implanting cell-matrix structure comprising matrix having attached thereto an effective amount of cells stably expressing a gene encoding biological modifier to stop or regress the excessive tissue proliferation |
| 02/17/2004 | US6692735 Truncated variant of c6 beta-chemokine leukotactin-1 polypeptide consisting of specified amino acid sequence |
| 02/17/2004 | CA2280279C Indole, indazole and benzimidazole derivatives as antithrombotic agents |
| 02/17/2004 | CA2274122C Improved chondrogenic differentiation of human mesenchymal stem cells |
| 02/17/2004 | CA2183755C Pharmaceutical preparation containing plasminogen activators |
| 02/13/2004 | CA2437064A1 Storage-stable, liquid fibrinogen formulation |
| 02/12/2004 | WO2004013633A2 Method for isolating atp binding proteins by means of immobolized protein inhibitors |
| 02/12/2004 | WO2004013631A2 Compositions and methods for diagnosis and therapy of cancer |
| 02/12/2004 | WO2004013356A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 02/12/2004 | WO2004013355A1 Sirna-mediated gene silencing with viral vectors |
| 02/12/2004 | WO2004013320A1 Regulation of human methyltransferase |
| 02/12/2004 | WO2004013319A2 Regulation of human esterase |
| 02/12/2004 | WO2004013313A2 Antisense nucleic acids |
| 02/12/2004 | WO2004013311A2 Compositions and methods relating to ovarian specific genes and proteins |
| 02/12/2004 | WO2004013306A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | WO2004013303A2 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease |
| 02/12/2004 | WO2004013300A2 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 02/12/2004 | WO2004013298A2 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections |
| 02/12/2004 | WO2004013294A2 Method of producing non-recombinant bmp-2 and use thereof |
| 02/12/2004 | WO2004013292A2 Extracellular messengers |
| 02/12/2004 | WO2004013289A2 Diagnosis of kidney damage and protection against same |
| 02/12/2004 | WO2004013288A2 Methods and kits for synthesis of sirna expression cassettes |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013283A2 Thioredoxin mutants and uses thereof |
| 02/12/2004 | WO2004013282A2 Bis (amino acid) molecular scaffolds |